Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100047274Phase 4Recruiting
Phase 4, randomised, single-blind trial of remimazolam (3 arms), sponsored by Dongguan People's Hospital. Primary endpoint: Anesthesia and sedation success rate. Started Mar 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100047274.